Clinical Trials Directory

Trials / Unknown

UnknownNCT01119534

Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin

Comparative Efficacy of the Suppository Composed by Guaiacol, Eucalyptol, Menthol and Camphor Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
270 (estimated)
Sponsor
Azidus Brasil · Industry
Sex
All
Age
2 Years – 6 Years
Healthy volunteers
Not accepted

Summary

It is believed that the suppository consisting of guaiacol, menthol, camphor and eucalyptol, by their pharmacological properties already established for each component, has the ability to reduce the signs and symptoms related to upper respiratory infections in a manner equivalent (not inferior) to medicine used as a comparator in this study and higher than the suppository containing only guaiacol concentration of 12.5 mg.

Conditions

Interventions

TypeNameDescription
DRUGGuaiacol, eucalyptol, menthol and camphor suppository2 times per day
DRUGguaiacol suppository2 times per day
DRUGGuaifenesin syrup4.19 mL - 4 in 4 hours

Timeline

Start date
2011-05-01
Primary completion
2011-10-01
Completion
2011-12-01
First posted
2010-05-07
Last updated
2011-01-28

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01119534. Inclusion in this directory is not an endorsement.